Imiquimod
| CAS No. | 99011-02-6 | Cat. No. | BCP05151 |
| Name | Imiquimod | ||
| Synonyms | S26308; S 26308 ; S26308; R837; R837; R 837; TMX-101; TMX 101; TMX101;Aldara;R 837;R-837;R837;Zyclara; | ||
| Formula | C14H16N4 | M. Wt | 240.3 |
| Description | Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist and is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod is a patient-applied cream used to treat certain diseases of the skin, including skin cancers (basal cell carcinoma, Bowen's disease, superficial squamous cell carcinoma, some superficial malignant melanomas, and actinic keratosis) as well as genital warts. However, Imiquimod is generally secondary to surgery, because surgery has a better chance to effectively treat at least some forms of skin cancer. It is known that imiquimod signals to the innate arm of the immune system through the toll-like receptor 7 (TLR7), commonly involved in pathogen recognition. Cells activated by imiquimod via TLR-7 secrete cytokines (primarily interferon-α (INF-α), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)). | ||
| Related Products | 99011-78-6（Imiquimod hydrochloride） | ||
| Pathways | Others Pathway | ||
| Targets | TLR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.